Enhancing Heart Allograft Function With the OCS Heart System Trial
Purpose
This trial is designed to evaluate the safety and effectiveness of the novel OCS Solution and OCS Functional Enhancer (OFE) to support FDA approval in both DBD and DCD heart transplantation. In addition, this trial will evaluate the performance of the novel OCS Solution and OFE compared to Static Cold Storage (SCS) in DBD heart transplantation to potentially demonstrate superiority.
Condition
- Heart Transplant
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Criteria
Part A - DCD Donor Hearts & DBD Donor Hearts Initially Deemed Unsuitable for Cold Storage
(Current Approved Indications):
Donor Inclusion Criteria
- Donor hearts are deemed clinically acceptable for transplantation after physical
examination of the donor hearts in the donor chest and/or on the back table in the
donor operating room.
- All DCD donors eligible for functional warm ischemic time criteria ≤ 30 minutes. WIT
defined as time from when mean systolic blood pressure (SBP) is <50mmHg (sustained
for at least 5 minutes) to aortic cross clamp and administration of old cardioplegia
in the donor.
- DBD donor hearts with an expected cross clamp of ≥ 4 hours
- DBD donor hearts with any of the following organ quality concerns, regardless of
cross clamp time:
- Donor age ≥ 40 years old
- Unknown downtime
- Insignificant CAD
- LVEF ≤ 50%
Donor Exclusion • Moderate to severe aortic incompetence
Part B - DBD Donor Hearts Currently Used with Cold Storage (New Indication):
Donor Inclusion Criteria
- Donor hearts are deemed clinically acceptable for transplantation after physical
examination of the donor hearts in the donor chest and/or on the back table in the
donor operating room.
- Eligible for randomization to OCS or SCS treatment arms.
- DBD donor hearts with an expected cross clamp time of < 4 hours.
Donor Exclusion
- Moderate to severe aortic incompetence
- DBD donor with any of the following organ quality concerns:
- Donor age ≥ 40 years old
- Unknown downtime
- Insignificant CAD
- LVEF ≤ 50%
Recipient Eligibility Criteria (for Part A and B Cohorts)
Inclusion
- Signed informed consent document and authorization to use and disclose protected
health information
- Heart transplant candidate
- Age ≥ 18 years old
Exclusion
• Participant in any other interventional clinical or investigational trials/programs
that may confound the outcomes of this trial
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Part A (OCS Heart) |
DCD Donor Hearts & DBD Donor Hearts Initially Deemed Unsuitable for Cold Storage (Current Approved Indications) |
|
|
Experimental Part B (OCS Heart) |
DBD Donor Hearts Currently Used with Cold Storage |
|
|
Active Comparator Part B (SCS) |
DBD Donor Hearts Currently Used with Cold Storage |
|
Recruiting Locations
Boston 4930956, Massachusetts 6254926 02114
More Details
- Status
- Recruiting
- Sponsor
- TransMedics